Healthcare Providers Increase their Efficacy in Photodynamic Therapy for Breast Cancer Resistance
New discoveries in photodynamic therapy (PDT) are benefitting cancer patients. As such, it has been found that, PDT is effective in treating multidrug-resistant breast cancer. Dysfunctional DNA repair genes and abnormal signal transduction are some of the major complications associated with breast cancer resistance. Hence, companies in the photodynamic therapy market are becoming increasingly aware about the complications of breast cancer resistance, and increasing the availability of PDT in hospitals and cancer treatment centers.
Cancer is projected to account for the highest revenue amongst all applications in the photodynamic therapy market, with an estimated value of ~US$ 2.3 billion by the end of 2023. This is why, healthcare companies are increasing awareness about PDT amongst breast cancer resistant patients. As such, PDT is being used as an alternative to broad-spectrum antibiotics-based therapy, thus minimizing the incidence of drug resistance. Companies are also increasing R&D to assess PDT-resistant cells to further study the impact of PDT on cellular targets. Healthcare providers are increasing their efficacy in PDT technology to achieve therapeutic relevance in appropriate photosensitizer (PS) level with its retention in the target tissue.
To know the scope of our report Get a Sample on Photodynamic Therapy Market
Dermoscopy Aids in Assessment of ALA Drugs Effective for AK Treatment
Growing incidence of actinic keratosis (AK) have led to innovations in the photodynamic therapy market. Dermoscopy serves as a useful tool for monitoring skin lesions during PDT and follow-up. Healthcare providers in the photodynamic therapy landscape are treating actinic keratosis (AK) patients with aminolevulinic acid (ALA) drugs. ALA agents are increasingly gaining popularity, and are anticipated to account for the highest revenue amongst all drugs in the photodynamic therapy market, with a projected value of ~US$ 4 billion by the end of 2027. Thus, healthcare providers in hospitals and dermatology clinics are offering topical ALA-PDT, since the treatment is widely approved by health commissions across various countries.
Dermoscopic monitoring is being used in tandem with PDT, and serves as a valuable and non-invasive technique, not just for diagnosing AK but also other serious skin diseases. The technique of dermoscopy is very useful for healthcare providers, since it can visualize the morphological structures of the inner layers of the skin that are not visible to the naked eye. Thus, dermoscopy is boosting the growth of the photodynamic therapy market.
Get a glimpse of the in-depth analysis through our Report Brochure
Customized Protocol Strategies Deliver Enhanced Clinical Translation
Healthcare providers in the photodynamic therapy market are adopting new strategies to achieve enhanced clinical translation. They are using the approach of customized protocols for the treatment of cancer and other infectious diseases. Companies are developing improved formulations of porphyrin-derivative (PD) compounds. This trend is projected to grow during the forecast period, since PD is projected to account for the second-highest revenue amongst all drugs in the photodynamic therapy market, with an estimated value of ~US$ 3 billion by the end of 2027. Hence, companies are developing intelligent PD molecules that can target specific cells and offer efficient drug delivery.
Companies in the photodynamic therapy market are developing strategies to improve transdermal ALA delivery. They are utilizing high-power CO2 lasers to produce microhole grating. Companies are increasing the production of ALA creams, since the grating procedure is followed by the application of the cream, assisted by ultrasound, to enhance the cream’s penetration into the holes. Another approach, such as the use of a soluble microneedle patch, helps in continuous delivery of ALA until the material is completely dissolved inside the lesion.
Innovative Photodynamic Devices Show the Way for Exponential Growth in Cancer Treatment
The photodynamic therapy and light-based therapy market are maturing at a rapid pace. However, prevailing challenges catering to the delivery of light to the right body part with adequate strength and specificity are likely to impede market growth. Another challenge is that, the photodynamic therapy market is highly consolidated, with only three market players accounting for ~90% of the market share. This makes it challenging for medium- and small-scale players to compete with these major players in the landscape.
In order to overcome the challenges of light delivery, companies are increasing their production capabilities to improve the efficacy of novel delivery systems in photodynamic therapy. To achieve the intended therapeutic effect on the target, small- and medium-scale players are increasing R&D to develop wirelessly-powered light-emitting devices that improve the specificity of light-based cancer therapy. Innovations in devices have facilitated the treatment for hard-to-detect microtumors and deeply-located lesions. Photodynamic devices are increasingly meeting the needs of cancer patients due to the availability of devices that do not require surgical suturing.
Expanding operations in future? To get the perfect launch ask for a custom report
Analysts’ Viewpoint
Phosistos protocol involving new light-emitting devices are gaining popularity for the effective treatment of actinic keratosis. Companies in the photodynamic therapy market are also gaining a strong hold though inorganic strategies such as label extensions. For instance, in September 2019, Biofrontera - a leading biopharmaceutical company, announced label extension for Ameluz(R) - an ALA used for the treatment of mild and moderate actinic keratosis in PDT.However, prevalent challenges in drug-resistant breast cancer treatment, such as blood vessel occlusion, collapse, and ultimate vascular shutdown, pose as a challenge in PDT. Thus, companies should increase research efforts to evaluate the advantages of photochemical internalization to facilitate the cytosolic delivery of macromolecular drugs to combat multidrug-resistant breast cancer.
Global Photodynamic Therapy Market: Overview
- This report analyzes the current scenario and future growth prospects of the global photodynamic therapy market. High prevalence and increase in the incidence of cancer, increase in the number of clinical trials, and rapidly growing bio-pharmaceutical industry are key factors that are projected to drive the global photodynamic therapy market during the forecast period.
- An article published by Soligenix (2019) states that, the company has conducted clinical research with SGX301 for the treatment of cutaneous T-cell lymphoma (CTCL). Fluorescent-light-activated synthetic hypericin is undergoing the pivotal Phase-3 trial in the U.S.
- Photodynamic therapy (PDT) has received clinical approval for use as a minimally-invasive therapeutic procedure, and it has been widely applied in the diagnosis and treatment of malignancies, including lung, esophageal, gastrointestinal, bladder, prostate, head & neck, and oral & skin cancer.
- Rise in the prevalence of skin disorders and cancer, surge in the demand for minimally-invasive procedures, and increase in economic burden of cancer are anticipated to drive the global photodynamic therapy market during the forecast period.
- The global photodynamic therapy market was valued at ~US$ 3 Bn in 2018, and is anticipated to reach ~US$ 11.8 Bn by 2027, expanding at a CAGR of ~17% from 2019 to 2027.
- North America and Europe were major markets for photodynamic therapy in 2018.
- The photodynamic therapy market in Asia Pacific is expected to expand at a high CAGR of ~18% during the forecast period.
Global Photodynamic Therapy Market: Key Segments
- In terms of product, the global photodynamic therapy market has been segmented into drugs and devices. The drugs segment has been sub-divided into porphyrin derivative (PD), aminolevulinic acid (ALA), chlorines and others. The porphyrin derivative (PD) segment is further divided into hematoporphyrin derivative (HpD), benzoporphyrin derivative (BPD), texaphyrins, and others. The devices segment is further divided into disposable fiber optic light delivery devices (DFOLDD) and diode laser. The drugs segment accounted for a major market share in 2018.
- Based on application, the global photodynamic therapy market has been segmented into cancer, actinic keratosis (AK), psoriasis, acne, and others. The cancer segment has been sub-divided into basal cell carcinoma, non-small cell lung cancer, head & neck cancer, and others. The cancer segment held a major share of the global photodynamic therapy market in 2018, and the trend is anticipated to continue during the forecast period.
- According to the American Society of Clinical Oncology (ASCO), head & neck cancer accounted for nearly 4% of all cancers in the U.S. in 2017. The report indicated that, approximately 65,000 individuals in the country would develop head & neck cancer in 2019.
- In terms of end user, the global photodynamic therapy market has been classified into hospitals, cosmetics & dermatology clinics, cancer treatment centers, and others. The hospitals segment accounted for a major market share in 2018.
- Market size and forecast for each of these segments of the global photodynamic therapy market have been provided for the period from 2017 to 2027. The CAGRs of the respective segments have also been provided for the period from 2019 to 2027, considering 2018 as the base year.
Global Photodynamic Therapy Market: Winning Imperatives
Approval of New Biologics for Photodynamic Therapy
- The approval of new biologics by regulatory authorities in developed as well as developing countries has enabled patients to gain access to new treatment options. A large number of pharmaceutical companies operating in the global photodynamic therapy market have received approval from the Food & Drug Administration (FDA), the European Commission, and China FDA. Some of the major drug approvals are as follows:
- In May 2016, Biofrotera AG received FDA approval for use of its combination topical prescription drug called Ameluz and medical device called BF-RhodoLED for PDT in the treatment of mild-to-moderate actinic keratosis (AK) on the face and the scalp.
- In November 2016, Biofrontera AG received approval from the European Commission for Ameluz.
Rapidly Growing Biopharmaceutical Industry in Developing Economies
- The pharmaceutical industry in developing economies has evolved significantly over the last few years, with increasing focus on research activities by government and private research institutes, growth in efforts toward the development of innovative pharmaceutical solutions, and rising focus on offering cost-effective therapeutic options for the treatment of various ailments.
- According to a report by India Brand Equity Foundation, the biotechnology industry in India, which comprises bio-pharmaceutical, bio-agriculture, bio-services, and bioinformatics, is likely to expand at an average growth rate of 22% from 2017 to 2025, to reach value of US$ 100 Bn by 2025.
Global Photodynamic Therapy Market: Competition
- Key players in the global photodynamic therapy market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies.
- Major companies profiled in the global photodynamic therapy market report are -
- Biofrontera AG
- Theralase Technologies Inc.
- Lumibird
- Quest PharmaTech Inc.
- Modulight, Inc.
- Galderma Laboratories L.P. (Nestlé)
- Sun Pharmaceutical Industries Ltd.
- SUS Advancing Technology Co., Ltd.
- In April 2018, Biofrontera AG launched Ameluz in combination with daylight-PDT.
- In August 2017, Biofrontera AG launched Ameluz and BF-RhodoLED in the market in Israel by partnering with Perrigo.
- In October 2016, Biofrontera AG launched AMELUZ gel (10%) and BF-RhodoLED lamp in the U.S. market.
- In January 2015, Modulight, Inc. launched the ML7710 laser platform. The device has various applications such as photoimmunotherapy, photodynamic therapy, surgical, dentistry, photo disinfection, aesthetic, vein treatment, and hyperthermia of tumors.
Global Photodynamic Therapy Market - Segmentation
|
Product |
Drugs
Devices
|
|
Application |
Cancer
Actinic Keratosis (AK) Psoriasis Acne Others |
|
End User |
Hospitals Cosmetics & Dermatology Clinics Cancer Treatment Centers Others |
|
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
Frequently Asked Questions
What is the total market worth of photodynamic therapy market?
Photodynamic therapy market to reach a value of US$ 11.8 Bn by 2027
What is the anticipated CAGR of the photodynamic therapy market in the forecast period?
Photodynamic therapy market is projected to expand at a CAGR of ~17% from 2019 to 2027
What are the key driving factors for the growth of the photodynamic therapy market?
Photodynamic therapy market is driven by increase in the prevalence as well as incidence of cancer and skin diseases
Which region is expected to project the highest market share in the global photodynamic therapy market?
North America accounted for a major share of the global photodynamic therapy market
Who are the key players in the global photodynamic therapy market?
Key players in the global photodynamic therapy market are Biofrontera AG, Theralase Technologies Inc., Lumibird, Quest PharmaTech Inc., Modulight, Inc., Galderma Laboratories L.P. (Nestlé)
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Photodynamic Therapy Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Photodynamic Therapy Market Analysis and Forecast, 2017–2027
5. Market Outlook
5.1. Epidemiology of Skin Disorders and Cancer
5.2. Major Companies in Global Photodynamic Therapy Market
5.3. Regulatory Scenario Assessment
5.4. Technological Advancements
5.5. Major Diseases Treated through Photodynamic Therapy
5.6. Patent Landscape Summary
6. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product
6.1. Introduction & Definition
6.2. Global Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
6.2.1. Drugs
6.2.1.1. Porphyrin Derivative (PD)
6.2.1.1.1. Hematoporphyrin Derivative (HpD)
6.2.1.1.2. Benzoporphyrin Derivative (BPD)
6.2.1.1.3. Texaphyrins
6.2.1.1.4. Others
6.2.1.2. Aminolevulinic acid (ALA)
6.2.1.3. Chlorines
6.2.1.4. Others
6.2.2. Devices
6.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
6.2.2.2. Diode Laser
6.3. Global Photodynamic Therapy Market Attractiveness, by Product
7. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application
7.1. Introduction
7.2. Global Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
7.2.1. Cancer
7.2.1.1. Basal Cell Carcinoma
7.2.1.2. Non-small Cell Lung Cancer
7.2.1.3. Head & Neck Cancer
7.2.1.4. Others
7.2.2. Actinic Keratosis (AK)
7.2.3. Psoriasis
7.2.4. Acne
7.2.5. Others
7.3. Global Photodynamic Therapy Market Attractiveness, by Application
8. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user
8.1. Introduction
8.2. Global Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
8.2.1. Hospitals
8.2.2. Cosmetics & Dermatology Clinics
8.2.3. Cancer Treatment Centers
8.2.4. Others
8.3. Global Photodynamic Therapy Market Attractiveness, by End-user
9. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region
9.1. Introduction
9.2. Global Photodynamic Therapy Market Value Forecast, by Region, 2017–2027
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Photodynamic Therapy Market Attractiveness, by Region
10. North America Photodynamic Therapy Market Analysis and Forecast
10.1. Introduction
10.2. North America Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
10.2.1. Drugs
10.2.1.1. Porphyrin Derivative (PD)
10.2.1.1.1. Hematoporphyrin Derivative (HpD)
10.2.1.1.2. Benzoporphyrin Derivative (BPD)
10.2.1.1.3. Texaphyrins
10.2.1.1.4. Others
10.2.1.2. Aminolevulinic Acid (ALA)
10.2.1.3. Chlorines
10.2.1.4. Others
10.2.2. Devices
10.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
10.2.2.2. Diode Laser
10.3. North America Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
10.3.1. Cancer
10.3.1.1. Basal Cell Carcinoma
10.3.1.2. Non-small Cell Lung Cancer
10.3.1.3. Head & Neck Cancer
10.3.1.4. Others
10.3.2. Actinic Keratosis (AK)
10.3.3. Psoriasis
10.3.4. Acne
10.3.5. Others
10.4. North America Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Cosmetics & Dermatology Clinics
10.4.3. Cancer Treatment Centers
10.4.4. Others
10.5. North America Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Photodynamic Therapy Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Photodynamic Therapy Market Analysis and Forecast
11.1. Introduction
11.2. Europe Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
11.2.1. Drugs
11.2.1.1. Porphyrin Derivative (PD)
11.2.1.1.1. Hematoporphyrin Derivative (HpD)
11.2.1.1.2. Benzoporphyrin Derivative (BPD)
11.2.1.1.3. Texaphyrins
11.2.1.1.4. Others
11.2.1.2. Aminolevulinic Acid (ALA)
11.2.1.3. Chlorines
11.2.1.4. Others
11.2.2. Devices
11.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
11.2.2.2. Diode Laser
11.3. Europe Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
11.3.1. Cancer
11.3.1.1. Basal Cell Carcinoma
11.3.1.2. Non-small Cell Lung Cancer
11.3.1.3. Head & Neck Cancer
11.3.1.4. Others
11.3.2. Actinic Keratosis (AK)
11.3.3. Psoriasis
11.3.4. Acne
11.3.5. Others
11.4. Europe Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Cosmetics & Dermatology Clinics
11.4.3. Cancer Treatment Centers
11.4.4. Others
11.5. Europe Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Photodynamic Therapy Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Photodynamic Therapy Market Analysis and Forecast
12.1. Introduction
12.2. Asia Pacific Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
12.2.1. Drugs
12.2.1.1. Porphyrin Derivative (PD)
12.2.1.1.1. Hematoporphyrin Derivative (HpD)
12.2.1.1.2. Benzoporphyrin Derivative (BPD)
12.2.1.1.3. Texaphyrins
12.2.1.1.4. Others
12.2.1.2. Aminolevulinic Acid (ALA)
12.2.1.3. Chlorines
12.2.1.4. Others
12.2.2. Devices
12.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
12.2.2.2. Diode Laser
12.3. Asia Pacific Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
12.3.1. Cancer
12.3.1.1. Basal Cell Carcinoma
12.3.1.2. Non-small Cell Lung Cancer
12.3.1.3. Head & Neck Cancer
12.3.1.4. Others
12.3.2. Actinic Keratosis (AK)
12.3.3. Psoriasis
12.3.4. Acne
12.3.5. Others
12.4. Asia Pacific Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Cosmetics & Dermatology Clinics
12.4.3. Cancer Treatment Centers
12.4.4. Others
12.5. Asia Pacific Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Photodynamic Therapy Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Photodynamic Therapy Market Analysis and Forecast
13.1. Introduction
13.2. Latin America Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
13.2.1. Drugs
13.2.1.1. Porphyrin Derivative (PD)
13.2.1.1.1. Hematoporphyrin Derivative (HpD)
13.2.1.1.2. Benzoporphyrin Derivative (BPD)
13.2.1.1.3. Texaphyrins
13.2.1.1.4. Others
13.2.1.2. Aminolevulinic Acid (ALA)
13.2.1.3. Chlorines
13.2.1.4. Others
13.2.2. Devices
13.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
13.2.2.2. Diode Laser
13.3. Latin America Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
13.3.1. Cancer
13.3.1.1. Basal Cell Carcinoma
13.3.1.2. Non-small Cell Lung Cancer
13.3.1.3. Head & Neck Cancer
13.3.1.4. Others
13.3.2. Actinic Keratosis (AK)
13.3.3. Psoriasis
13.3.4. Acne
13.3.5. Others
13.4. Latin America Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Cosmetics & Dermatology Clinics
13.4.3. Cancer Treatment Centers
13.4.4. Others
13.5. Latin America Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Photodynamic Therapy Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Photodynamic Therapy Market Analysis and Forecast
14.1. Introduction
14.2. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
14.2.1. Drugs
14.2.1.1. Porphyrin Derivative (PD)
14.2.1.1.1. Hematoporphyrin Derivative (HpD)
14.2.1.1.2. Benzoporphyrin Derivative (BPD)
14.2.1.1.3. Texaphyrins
14.2.1.1.4. Others
14.2.1.2. Aminolevulinic Acid (ALA)
14.2.1.3. Chlorines
14.2.1.4. Others
14.2.2. Devices
14.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
14.2.2.2. Diode Laser
14.3. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
14.3.1. Cancer
14.3.1.1. Basal Cell Carcinoma
14.3.1.2. Non-small Cell Lung Cancer
14.3.1.3. Head & Neck Cancer
14.3.1.4. Others
14.3.2. Actinic Keratosis (AK)
14.3.3. Psoriasis
14.3.4. Acne
14.3.5. Others
14.4. Middle East & Africa Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
14.4.1. Hospitals
14.4.2. Cosmetics & Dermatology Clinics
14.4.3. Cancer Treatment Centers
14.4.4. Others
14.5. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Global Photodynamic Therapy Market Share Analysis, by Company (2018)
15.2. Company Profiles
15.2.1. Biofrontera AG
15.2.1.1. Company Description
15.2.1.2. Business Overview
15.2.1.3. Financial Overview
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. Theralase Technologies Inc.
15.2.2.1. Company Description
15.2.2.2. Business Overview
15.2.2.3. Financial Overview
15.2.2.4. Strategic Overview
15.2.2.5. SWOT Analysis
15.2.3. LUMIBIRD
15.2.3.1. Company Description
15.2.3.2. Business Overview
15.2.3.3. SWOT Analysis
15.2.4. Quest PharmaTech Inc.
15.2.4.1. Company Description
15.2.4.2. Business Overview
15.2.4.3. Financial Overview
15.2.4.4. Strategic Overview
15.2.4.5. SWOT Analysis
15.2.5. Modulight, Inc.
15.2.5.1. Company Description
15.2.5.2. Business Overview
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6. Galderma Laboratories L.P. (Nestlé)
15.2.6.1. Company Description
15.2.6.2. Business Overview
15.2.6.3. Financial Overview
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Sun Pharmaceutical Industries Ltd.
15.2.7.1. Company Description
15.2.7.2. Business Overview
15.2.7.3. Financial Overview
15.2.7.4. Strategic Overview
15.2.7.5. SWOT Analysis
15.2.8. SUS Advancing Technology Co., Ltd
15.2.8.1. Company Description
15.2.8.2. Business Overview
15.2.8.3. SWOT Analysis
List of Tables
Table 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 03: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027
Table 04: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 05: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 06: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 07: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 08: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 09: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 10: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 11: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 12: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027
Table 13: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 14: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 15: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 16: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 17: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 19: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drug, 2017–2027
Table 20: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027
Table 21: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 22: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 23: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 24: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 25: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 26: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 27: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 28: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027
Table 29: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 30: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 31: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 32: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 33: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 34: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 35: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 36: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027
Table 37: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 38: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 39: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 40: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 41: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 42: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 43: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 44: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027
Table 45: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 46: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 47: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 48: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027
List of Figures
Figure 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, 2017–2027
Figure 02: Global Photodynamic Therapy Market Value Share (%), by Product, 2018
Figure 03: Global Photodynamic Therapy Market Value Share (%), by Drugs, 2018
Figure 04: Global Photodynamic Therapy Market Value Share (%), by Application, 2018
Figure 05: Global Photodynamic Therapy Market Value Share (%), by Region, 2018
Figure 06: Global Photodynamic Therapy Market Value Share (%), by Product, 2018 and 2027
Figure 07: Global Photodynamic Therapy Market Value Share (%), by Drugs, 2018 and 2027
Figure 08: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs, 2017–2027
Figure 09: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Devices, 2017–2027
Figure 10: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Porphyrin Derivative (PD), 2017–2027
Figure 11: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aminolevulinic Acid (ALA), 2017–2027
Figure 12: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chlorines, 2017–2027
Figure 13: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 14: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DFOLDD, 2017–2027
Figure 15: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diode Laser, 2017–2027
Figure 16: Global Photodynamic Therapy Market Attractiveness, by Product, 2019–2027
Figure 17: Global Photodynamic Therapy Market Attractiveness, by Drugs, 2019–2027
Figure 18: Global Photodynamic Therapy Market Attractiveness, by Devices, 2019–2027
Figure 19: Global Photodynamic Therapy Market Value Share (%), by Application, 2018 and 2027
Figure 20: Global Photodynamic Therapy Market Attractiveness, by Application, 2019–2027
Figure 21: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer, 2017–2027
Figure 22: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Actinic Keratosis (AK), 2017–2027
Figure 23: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Psoriasis, 2017–2027
Figure 24: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Acne, 2017–2027
Figure 25: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 26: Global Photodynamic Therapy Market Value Share (%), by End-user, 2018 and 2027
Figure 27: Global Photodynamic Therapy Market Attractiveness Analysis, by End-user
Figure 28: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027
Figure 29: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cosmetics & Dermatology Clinics, 2017–2027
Figure 30: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer Treatment Centers, 2017–2027
Figure 31: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 32: Global Photodynamic Therapy Market Value Share Analysis, by Region, 2018 and 2027
Figure 33: Global Photodynamic Therapy Market Attractiveness Analysis, by Region, 2019-2027
Figure 34: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 35: North America Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 36: North America Photodynamic Therapy Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 37: North America Photodynamic Therapy Market Value Share, by Product, 2018 and 2027
Figure 38: North America Photodynamic Therapy Market Attractiveness Analysis, by Product, 2019–2027
Figure 39: North America Photodynamic Therapy Market Value Share, by Application, 2018 and 2027
Figure 40: North America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2019–2027
Figure 41: North America Photodynamic Therapy Market Value Share, by End-user, 2018 and 2027
Figure 42: North America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2019–2027
Figure 43: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
Figure 44: Europe Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 45: Europe Photodynamic Therapy Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 46: Europe Photodynamic Therapy Market Value Share, by Product, 2018 and 2027
Figure 47: Europe Photodynamic Therapy Market Attractiveness Analysis, by Product, 2019–2027
Figure 48: Europe Photodynamic Therapy Market Value Share, by Application, 2018 and 2027
Figure 49: Europe Photodynamic Therapy Market Attractiveness Analysis, by Application, 2019–2027
Figure 50: Europe Photodynamic Therapy Market Value Share, by End-user, 2018 and 2027
Figure 51: Europe Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2019–2027
Figure 52: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 53: Asia Pacific Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 54: Asia Pacific Photodynamic Therapy Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 55: Asia Pacific Photodynamic Therapy Market Value Share, by Product, 2018 and 2027
Figure 56: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Product, 2019–2027
Figure 57: Asia Pacific Photodynamic Therapy Market Value Share, by Application, 2018 and 2027
Figure 58: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Application, 2019–2027
Figure 59: Asia Pacific Photodynamic Therapy Market Value Share, by End-user, 2018 and 2027
Figure 60: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2019–2027
Figure 61: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
Figure 62: Latin America Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 63: Latin America Photodynamic Therapy Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 64: Latin America Photodynamic Therapy Market Value Share, by Product, 2018 and 2027
Figure 65: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Product, 2019–2027
Figure 66: Latin America Photodynamic Therapy Market Value Share, by Application, 2018 and 2027
Figure 67: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2019–2027
Figure 68: Latin America Photodynamic Therapy Market Value Share, by End-user, 2018 and 2027
Figure 69: Latin America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2019–2027
Figure 70: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
Figure 71: Middle East & Africa Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 72: Middle East & Africa Photodynamic Therapy Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 73: Middle East & Africa Photodynamic Therapy Market Value Share, by Product, 2018 and 2027
Figure 74: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Product, 2019–2027
Figure 75: Middle East & Africa Photodynamic Therapy Market Value Share, by Application, 2018 and 2027
Figure 76: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Application, 2019–2027
Figure 77: Middle East & Africa Photodynamic Therapy Market Value Share, by End-user, 2018 and 2027
Figure 78: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2019–2027
